Rituximab Therapy in Idiopathic Membranous Nephropathy: A 2-Year Study

Background and objectives: It was postulated that in patients with membranous nephropathy (MN), four weekly doses of Rituximab (RTX) would result in more effective B cell depletion, a higher remission rate, and maintaining the same safety profile compared with patients treated with RTX dosed at 1 g...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Fervenza, Fernando C., Abraham, Roshini S., Erickson, Stephen B., Irazabal, Maria Valentina, Eirin, Alfonso, Specks, Ulrich, Nachman, Patrick H., Bergstralh, Eric J., Leung, Nelson, Cosio, Fernando G., Hogan, Marie C., Dillon, John J., Hickson, LaTonya J., Li, Xujian, Cattran, Daniel C.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Nephrology 2010
Onderwerpen:
Original Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2994079/
https://ncbi.nlm.nih.gov/pubmed/20705965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.05080610
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items